Pricing Log in Create free account
Saturday 10 October 2026 Export all AZN data to Excel Powerpack

AstraZeneca PLC

AZN Healthcare Drug Manufacturers General

AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.41%, EPS grew 1.90%, free cash flow fell 107.5% and total debt fell 5.50%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five; insiders bought in the last twelve months.

159.20 0.42 +0.26%
Market cap
$246.3B
P/E
23.6×
Fwd P/E
23.4×
Dividend yield
2.02%
F-score
9/9
Altman Z
6.26
Beneish M
−2.51
Dividend safety
54/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

AstraZeneca PLC (AZN) P/E ratio

Alert me on P/E ratio

As of 9 October 2026, AstraZeneca PLC (AZN) trades at a P/E ratio of 23.6×. Over the past ten years it has ranged from 0.0× (September 2022) to 447× (March 2022); the current reading is higher than 10% of that period. That is in line with the Drug Manufacturers General industry median of 23.6× and in line with the Healthcare sector median of 22.5×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 27.9× (3.06%)
FY2024 28.7× (18.92%)
FY2023 35.4× (45.30%)
FY2022 64.8× (83.31%)
FY2021 388× 855.49%
FY2020 40.6× (56.80%)
FY2019 94.1× 110.54%
FY2018 44.7× 50.29%
FY2017 29.7× 49.14%
FY2016 19.9× (33.65%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 28.1× (4.28%)
Mar 2026 29.4× 5.51%
Dec 2025 27.9× 10.38%
Sep 2025 25.2× (3.21%)
42 more quarters

Against its own ten years

Low 0.0× High 447×
Ten-year median 36.3×
Current reading's percentile 7

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.4×
BMY Bristol Myers Squibb Company compare 13.0×
NVS Novartis AG compare 21.6×
AZN AstraZeneca PLC 23.6×
AMGN Amgen Inc. compare 25.6×
PFE Pfizer Inc. compare 37.2×
ABBV AbbVie Inc. compare 78.1×
MRK Merck & Co., Inc. compare 116×
Drug Manufacturers General industry median 23.6×
Healthcare sector median 22.5×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AZN